NxStage Medical, Inc. news

   Watch this stock
Showing stories 1 - 10 of about 85   

Articles published

NXTM 18.90 +0.10 (0.53%)
price chart
NxStage Medical Inc. (NXTM) Hits New 52-week High During January 23 Session
NxStage Medical Inc. (NXTM) hit a new 52-week high yesterday, reaching a peak of $19.17 after opening at $18.79 and closing at $18.90 for a move of $0.53%.
Why NxStage Medical Inc. Stock Surged Higher
Why it's happening: For the quarter, NxStage Medical reported a 13% increase in revenue to a record $75.3 million, which happened to be higher than the prior guidance issued by the company of $71 million-$72.5 million issued during its second-quarter ...
Why Are Traders Paying Attention To Uranium Energy Corp.(NYSEMKT:UEC ...  Scibility Media
Related articles »  
​ReWalk Robotics names NxStage Medical exec as new CFO
Kevin W. Hershberger, former controller and chief accounting officer at NxStage Medical Inc., as CFO starting Jan. 1. Ami Kraft, who had been serving as ReWalk's CFO, to a new role as general manager of ReWalk's Israel organization, and will assume his ...
Update: NxStage Medical Q3 2014 Earnings (NXTM)
NxStage Medical's (NASDAQ:NXTM) third-quarter 2014 revenue grew 13% to a record $75.3 million, compared to $66.9 million in the year-ago period.
NxStage Launches New Streamline Express Dialyzer With Pre-attached Blood ...  MarketWatch
Related articles »  
Why NxStage Medical Inc. Shares Slumped
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.
Related articles »  
Short Interest of NxStage Medical, Inc. Drops by 6.8%
The short interest in NxStage Medical, Inc. (NASDAQ:NXTM) has declined from 3,578,925 on December 15,2014 to 3,336,393 on December 31,2014.
Nxstage Medicals Home Dialysis System Gets FDA Go-Ahead
One of the leading manufacturers of innovative dialysis products - Nxstage Medical, Inc. (NXTM - Snapshot Report) - recently secured the U.S.
Nxstage Medical's Home Dialysis System Gets FDA Go-Ahead - Analyst Blog  Nasdaq
Update: NxStage Bagged FDA Clearance For System One For Nocturnal ...  Seeking Alpha
Related articles »  
NxStage Medical, Inc. Discloses Insider Trading
NxStage Medical, Inc. (NASDAQ:NXTM),The President of NxStage Medical Inc, Turk Joseph E Jr sold 2,350 shares at $18.44 on December 23, 2014.
Investor Alert on Insider Trading: NxStage Medical, Inc. , Empire Resorts Inc  Wall Street Pulse
Related articles »  
NxStage Medical Reaches New 52-Week High at $19.17 (NXTM)
NxStage Medical (NASDAQ:NXTM) last announced its earnings results on Thursday, November 6th. The company reported ($0.11) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.13) by $0.02.
NxStage Medical, Inc. (NXTM) news: NxStage Medical's CEO Discusses Q4 ...
Good day, ladies and gentlemen, and welcome to the NxStage Medical's Fourth Quarter Fiscal 2013 Financial Results Conference Call.
Related articles »